Alpha Profiles · Company Profile

Celldex Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/celldex-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: CLDX
Verification: Partially verified
Last reviewed: 2026-09-20T04:45:51.509003+00:00

Overview

Alpha's canonical identity and public leadership record for Celldex Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

8 public records

Anthony S. Marucci

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-050884Apr 29, 2026

Elaine D. Crowley

Senior Vice President, Chief Product Development Officer

State: confirmed
Effective: From Apr 29, 2026
Confidence: 94%
Evidence: CLDX DEF 14A executive officersApr 29, 2026

Elizabeth Crowley

Senior Vice President and Chief Product Development Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-050884Apr 29, 2026

Margo Heath-Chiozzi

Senior Vice President, Regulatory Affairs

State: confirmed
Effective: From Apr 29, 2026
Confidence: 94%
Evidence: CLDX DEF 14A executive officersApr 29, 2026

Margo Heath-Chiozzi, M.D.

Senior Vice President, Regulatory Affairs

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-050884Apr 29, 2026

Sam Martin

Senior Vice President, Chief Financial Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-050884Apr 29, 2026

Tibor Keler

Executive Vice President and Chief Scientific Officer

State: confirmed
Effective: From Apr 29, 2026
Confidence: 94%
Evidence: CLDX DEF 14A executive officersApr 29, 2026

Tibor Keler, Ph.D.

Executive Vice President and Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-050884Apr 29, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 20, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.